Discover the Science of Health
A team of researchers led by Dr. Michael McAlpine of Princeton University have developed a gold- and carbon-based biosensor that can be affixed to a tooth [1]. The purpose of the sensor, which is made up primarily of a very strong form of carbon called graphene, is to detect sequences of DNA that are specific to pathogenic bacteria.
Mobile technology company Qualcomm announced today the formation of a new subsidiary, Qualcomm Life. The subsidiary will run the company’s former Wireless Health business. Qualcomm Life was unveiled today at the mHealth Summit in Washington D.C. As part of the launch, Qualcomm presented the 2net hub, a mobile device designed to plug into a wall socket and provide connectivity for a wide range of medical devices. The 2net platform allows for the wireless transmission of health data from medical devices to various locations, such as a hospital or doctor’s office.
Over 40 medical device manufacturers, application developers, health care services companies and payors are either integrating with or considering the 2net ecosystem.
Qualcomm Life will also establish a $100 million fund, managed by Qualcomm’s venture arm, to invest in wireless technology adoption in the healthcare industry. Desired developments include biosensors, medication compliance, wellness, remote diagnosis or monitoring and analytics.
According to Rick Valencia, vice president and general manager of Qualcomm Life:
Qualcomm Life was founded, in part, to assist medical device manufacturers who approached Qualcomm for help when their own wireless connectivity attempts became untenable due to technology selection errors, unscalable deployment models and prohibitively high operational support costs. Our services, including integration on the 2net platform, remove the burden for medical device manufacturers of a large technical development effort, providing integration with mobile carriers and solving the operational complexities of supporting wireless medical device data in the field.
Source: Qualcomm Life
iglucose is a mobile health device and wireless communication system for diabetes management. Recently cleared by the FDA, iglucose simplifies disease management by automatically collecting, storing and transmiting blood glucose readings to create logbooks and trend reports.
From the iglucose website:
iglucose is a diabetes management solution that provides a convenient way to collect, store and automatically transmit blood glucose readings from compatible glucometers in real time. iglucose easily connects to industry leading, data-capable glucometers. Once glucometer data is transmitted to a secure central database, logbooks and trend reports are automatically created and can be communicated to individuals, family members, caregivers and health care professionals in order to collaborate for better outcomes. iglucose is mobile: it can be used anytime, anywhere.
The iglucose is the first core product in a suite of diabetes management technologies from PositiveID Corporation.
Source: PRWeb
